Seegene Novaplex MPXV/OPXV Plus, HSV-1&2/VZV/MPXV Assays

Seegene has launched two new research-use-only PCR assays with enhanced ability to detect mpox clade I, which is currently associated with higher transmission and mortality rates than mpox clade II.   

The Novaplex MPXV/OPXV plus Assay detects three targets that can cause mpox disease. Specifically, it detects orthopoxvirus (OPXV) and mpox virus (MPXV), and includes specific confirmation of MPXV clade I. The assay also meets the World Health Organization's target product profiles (TPPs) for mpox assays and aligns with preferred target analyte criteria for distinguishing between clades I and II.  

The firm has also launched the Novaplex HSV-1&2/VZV/MPXV Assay to simultaneously detect MPXV, herpes simplex virus types 1 and 2, and varicella-zoster virus. This test also complies with TPPs issued by the WHO.